# Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

> **NCT01319526** · — · TERMINATED · sponsor: **AIDS Malignancy Consortium** · enrollment: 1 (actual)

## Conditions studied

- Lymphoma
- Nonneoplastic Condition

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** RNA analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01319526
- **Lead sponsor:** AIDS Malignancy Consortium
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Parent protocol (SWOG S0816 / AMC-073) discontinued
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319526, "Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01319526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*